NCT07218107Completed
Neurostimulation Exosuit Augmented Training (NEAT) in the Clinic
Neurostimulation Exosuit Augmented Training (NEAT) in the Clinic Using a Wearable Propulsion Neuroprosthesis
Source: ClinicalTrials.gov · Last updated 20 Oct 2025
Brief summary (registry, in English)
The primary goal of this study is to understand the feasibility and rehabilitative effects of a Neurostimulation Exosuit Augmented Training (NEAT) program designed to provide high-intensity gait training in progressively challenging environments for individuals in the chronic phase of stroke recovery. The investigators will monitor feasibility of the training program and assess walking endurance and energy efficiency before and after the training to quantify effects of the training program on the recovery of walking function driven by improvements in forward propulsion and symmetry between limbs. Participants will complete pre-training and post-training evaluations alongside 12 gait training sessions across 4-5 weeks.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 4 (actual)
- First submitted
- 2 Jul 2024
- Start date
- 4 Jun 2024
- Primary completion date
- 23 Oct 2024
- Lead sponsor
- Boston University Charles River Campus
- Diseases
- Stroke
- NCT number
- NCT07218107
What you commit to
- Study type: Interventional
- Participants enrolled: 4
- From 4 Jun 2024 to the primary completion date, 23 Oct 2024
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Actively receiving physical therapy for walking
- More than 2 unexplained falls in the previous month
- Pacemakers or similar electrical implants that could be affected by electrical stimulation
- Metal implants directly under the stimulation sites
Other illness
- NIH Stroke Scale Question 1b score \> 1 and Question 1c score \> 0
- History of cerebellar stroke
- Skin allergy or other condition sensitive to the adhesive from transcutaneous neurostimulation electrode pads
- Other medical, orthopedic, and neurological conditions that prevent full participation in the research
Other
- Inability to communicate with investigators
- Visual neglect or hemianopia
- Pressure ulcers or skin wounds located near human-device interface sites
Who the study is looking for
- Age 18 - 80 years old
- History of stroke event occurring at least 6 months ago
- Observable gait deficits characteristic of post-stroke hemiparesis
- Independent ambulation for at least 30 meters (with an assistive device if needed but without a rigid brace for the ankle)
- Ankle dorsiflexion range of motion at least to neutral (i.e., 90 degrees between the shank and the foot)
- Resting heart rate between 40 - 100 bpm (inclusive)
- Resting blood pressure between 90/60 and 170/90 mmHg (inclusive)
- HIPAA authorization to allow communication with healthcare provider as needed during the study period
- Medical clearance by a physician
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Neuromotor Recovery Laboratory Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
| Center for Neurorehabilitation Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.